[HTML][HTML] Blood-brain barrier: from physiology to disease and back
MD Sweeney, Z Zhao, A Montagne… - Physiological …, 2018 - journals.physiology.org
The blood-brain barrier (BBB) prevents neurotoxic plasma components, blood cells, and
pathogens from entering the brain. At the same time, the BBB regulates transport of …
pathogens from entering the brain. At the same time, the BBB regulates transport of …
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
MD Sweeney, AP Sagare, BV Zlokovic - Nature Reviews Neurology, 2018 - nature.com
The blood–brain barrier (BBB) is a continuous endothelial membrane within brain
microvessels that has sealed cell-to-cell contacts and is sheathed by mural vascular cells …
microvessels that has sealed cell-to-cell contacts and is sheathed by mural vascular cells …
Age-associated physiological and pathological changes at the blood–brain barrier: A review
F Erdő, L Denes, E de Lange - Journal of Cerebral Blood …, 2017 - journals.sagepub.com
The age-associated decline of the neurological and cognitive functions becomes more and
more serious challenge for the developed countries with the increasing number of aged …
more serious challenge for the developed countries with the increasing number of aged …
Glucose transporters at the blood-brain barrier: function, regulation and gateways for drug delivery
SG Patching - Molecular neurobiology, 2017 - Springer
Glucose transporters (GLUTs) at the blood-brain barrier maintain the continuous high
glucose and energy demands of the brain. They also act as therapeutic targets and provide …
glucose and energy demands of the brain. They also act as therapeutic targets and provide …
[HTML][HTML] Review of current strategies for delivering Alzheimer's disease drugs across the blood-brain barrier
KH Wong, MK Riaz, Y Xie, X Zhang, Q Liu… - International journal of …, 2019 - mdpi.com
Effective therapy for Alzheimer's disease is a major challenge in the pharmaceutical
sciences. There are six FDA approved drugs (eg, donepezil, memantine) that show some …
sciences. There are six FDA approved drugs (eg, donepezil, memantine) that show some …
[HTML][HTML] The blood-brain barrier in health and chronic neurodegenerative disorders
BV Zlokovic - Neuron, 2008 - cell.com
The blood-brain barrier (BBB) is a highly specialized brain endothelial structure of the fully
differentiated neurovascular system. In concert with pericytes, astrocytes, and microglia, the …
differentiated neurovascular system. In concert with pericytes, astrocytes, and microglia, the …
Cerebral microvascular pathology in ageing and neurodegeneration
WR Brown and CR Thore (2011) Neuropathology and Applied Neurobiology37, 56–74
Cerebral microvascular pathology in ageing and neurodegeneration This review of age …
Cerebral microvascular pathology in ageing and neurodegeneration This review of age …
Brain fuel metabolism, aging, and Alzheimer's disease
Lower brain glucose metabolism is present before the onset of clinically measurable
cognitive decline in two groups of people at risk of Alzheimer's disease---carriers of …
cognitive decline in two groups of people at risk of Alzheimer's disease---carriers of …
Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer's disease
RD Bell, BV Zlokovic - Acta neuropathologica, 2009 - Springer
Vascular dysfunction has a critical role in Alzheimer's disease (AD). Recent data from brain
imaging studies in humans and animal models suggest that cerebrovascular dysfunction …
imaging studies in humans and animal models suggest that cerebrovascular dysfunction …
The role of environmental exposures in neurodegeneration and neurodegenerative diseases
JR Cannon, JT Greenamyre - Toxicological Sciences, 2011 - academic.oup.com
Neurodegeneration describes the loss of neuronal structure and function. Numerous
neurodegenerative diseases are associated with neurodegeneration. Many are rare and …
neurodegenerative diseases are associated with neurodegeneration. Many are rare and …